Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.

Kristen K. Rumer, Miriam D. Post, Rhea S. Larivee, Martina Zink, Jill Uyenishi, Anita Kramer, Deanna Teoh, Kevin Bogart, Virginia D. Winn

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Sialic acid immunoglobulin-like lectin (Siglec)-6 is a transmembrane receptor that binds leptin. Leptin is an obesity-associated peptide hormone overexpressed in gestational trophoblastic disease (GTD). GTD encompasses several placental abnormalities that range from benign to malignant. Among GTD, molar placentas are characterized by excess proliferation, whereas gestational trophoblastic neoplasias (GTN) have characteristically aggressive invasion. We hypothesized that in GTD, Siglec-6 expression would increase with disease severity and that Siglec-6 and leptin would promote proliferation, inhibit apoptosis and/or promote invasion. Siglec-6 expression patterns were evaluated with particular attention to the diagnostic utility of Siglec-6 in GTD (controls: normal placentas (n=32), hydropic abortus placentas (n=7), non-GTD reproductive tract cancers (n=2); GTD: partial moles (PM; n=11), complete moles (n=24), GTN (n=6)). In normal placentas, Siglec-6 expression dramatically decreased after 8 weeks gestation. Complete molar placentas had significantly higher Siglec-6 expression than controls, but expression was not significantly different from PM. In GTN, Siglec-6 expression was low. These data suggest that Siglec-6 may have diagnostic utility for distinguishing complete moles from normal and hydropic abortus placentas. Functional studies in choriocarcinoma-derived BeWO cells demonstrated a complex interplay between Siglec-6 expression and leptin exposure. In cells lacking Siglec-6, leptin treatment promoted invasion, likely through interaction with LepR leptin receptor, without affecting proliferation or apoptosis. Siglec-6 expression promoted proliferation in a leptin-dependent manner, but protected cells from apoptosis and promoted invasion in a leptin-independent manner. We propose that Siglec-6 and leptin play a role in the aberrant properties characteristic of GTD, namely excess proliferation and invasion.

Original languageEnglish (US)
Pages (from-to)827-840
Number of pages14
JournalEndocrine-related cancer
Volume19
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint Dive into the research topics of 'Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.'. Together they form a unique fingerprint.

Cite this